IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31

IQVIA HOLDINGS INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026

$265.88−1.02 (-0.38%)

Close on Oct 19, 2026

Market cap: $44.48B
P/E (TTM): 33.0
Dividend yield: –

IQVIA HOLDINGS INC. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31
Revenue	16,310	15,405	14,984	14,410	13,874	11,359	11,088	10,412	9,702	6,815	5,737	5,460	5,100	4,866	4,328
Cost of Revenue	10,880	10,030	9,745	9,382	9,233	7,500	7,300	6,746	6,301	3,236	2,705	2,664	2,471	2,459	2,153
Gross Profit	5,430	5,375	5,239	5,028	4,641	3,859	3,788	3,666	3,401	3,579	3,032	2,796	2,628	2,406	2,175
Research & Development	–	–	–	–	–	–	–	–	–	–	3.34	5.79	4.96	10	9.99
Selling, General & Admin	1,999	1,992	2,053	2,071	1,964	1,789	1,734	1,716	1,622	1,016	815	781	861	818	762
Advertising Expenses	–	–	–	–	–	–	–	–	–	–	13	16	15	15	13
Operating Income	2,182	2,202	1,977	1,799	1,393	731	777	741	665	576	646	590	462	396	345
Interest Expense	729	670	672	416	375	416	447	414	346	144	101	101	124	-134	109
Interest & Investment Income	45	47	36	13	6.00	6.00	9.00	8.00	7.00	4.00	4.00	4.00	3.94	3.07	3.94
Income from Equity Investments	22	5.00	0	-12	6.00	7.00	-9.00	15	10	-4.00	8.00	5.00	-1.12	2.57	71
Other Non-Operating Income	99	90	124	-33	130	65	37	-5.00	-13	11	-2.00	8.00	0.19	3.57	-9.07
Merger & Restructuring Charges	105	67	84	28	20	52	75	68	63	71	30	9.00	14	19	22
Asset Impairment Charges	0	0	0	0	0	0	0	0	40	28	2.00	0	0	0	12
Gain (Loss) on Investments	44	22	20	-27	16	25	43	-3.00	8.00	13	-1.00	5.00	0	0	–
Gain (Loss) on Sale of Assets	–	0	0	10	0	0	-1.00	0	1.00	1.00	1.00	1.00	1.15	0.54	1.11
Pretax Income	1,591	1,669	1,459	1,363	1,128	373	352	328	294	416	539	501	323	267	185
Income Tax Expense	252	301	101	260	163	72	116	59	-992	325	159	149	96	93	15
Net Income incl. Noncontrolling Interests	1,361	1,373	1,358	1,091	971	308	227	284	1,296	87	388	357	226	177	240
Minority Interest in Earnings	1.00	0	0	0	5.00	29	36	25	19	15	1.00	0.12	-0.56	-0.92	1.45
Net Income	1,360	1,373	1,358	1,091	966	279	191	259	1,277	72	387	357	227	178	242
EPS (Basic)(per share)	7.91	7.57	7.39	5.82	5.05	1.46	0.98	1.27	5.86	0.48	3.15	2.78	1.83	1.53	2.08
EPS (Diluted)(per share)	7.84	7.49	7.29	5.72	4.95	1.43	0.96	1.24	5.74	0.47	3.08	2.72	1.77	1.51	2.05
Shares Outstanding (Basic, Weighted)(shares)	172	181	184	188	191	191	195	204	218	149	123	128	124	116	116
Shares Outstanding (Diluted, Weighted)(shares)	174	183	186	191	195	195	200	208	223	152	126	131	128	118	118
EBITDA	3,326	3,316	3,102	2,929	2,657	2,018	1,979	1,882	1,676	865	774	711	570	495	437

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 33.0%
Operating margin: 13.0%
Net margin: 8.1%
Return on equity, FY2025: 21.6%

Financial strength

Current ratio: 0.71
Debt to equity: 2.59
Debt to assets: 53.5%
Cash to current liabilities: 21.7%

Valuation

P/E ratio: 33.0
Price to sales: 2.62
Price to book: 7.21
Dividend yield: –